ABOUT THE

SYMPOSIUM

OVERVIEW

 Despite the significance of T cells in neuroinflammation and neurodegenerative processes, the identification of T cell targets in these contexts remains challenging. In recent years, advancements in basic and clinical neuroimmunology have improved our comprehension of T cell pathophysiology in neurological disorders. However, research efforts often exist in isolation, lacking a unified platform for meaningful collaboration. To address this gap, “T Cells in the Brain 2027 (TCB2027): Decoding T Cell Targets in Neurodegenerative Diseases” aims to consolidate recent scientific progress and integrative approaches towards T cell-based therapy. TCB2027 will bring together experts in the field to share cutting-edge data and technologies and foster interdisciplinary discussions that can catalyze the development of therapeutic interventions targeting T cells in neurodegenerative diseases.

Confirmed speakers : (MORE TO BE ANNOUNCED)


Clare Baecher-Allan, Ph.D. (Brigham and Women's Hospital)
Michael Birnbaum, Ph.D. (Massachusetts Institute of Technology)
Elizabeth Bradshaw, Ph.D. (Mayo Clinic, AZ)
Randy Brutkiewicz, Ph.D. (Indiana University School of Medicine)
Laura Campisi, Ph.D. (Washington University School of Medicine)
Sarah Carpanini, Ph.D. (Cardiff University, UK)

Fiona Ducotterd, Ph.D. (University College London)
Wassim Elyaman, Ph.D. (Mayo Clinic, AZ)
Pietro Fratta, M.D., Ph.D. (University College London, UK)
Ozgun Gokce, Ph.D. (University of Bonn, Germany)
David Hafler, M.D. (Yale University)
Ashley Harms, Ph.D. (University of Alabama)
Charles Howe, Ph.D. (Mayo Clinic)
Jaime Imitola, M.D. (University of Connecticut Health)
Saef Izzy, M.D. (Massachusetts General Hospital / Harvard Medical School)
Ning (Jenny) Jiang, Ph.D. (University of Pennsylvania)
Aaron Johnson, Ph.D. (Mayo Clinic)
Ayano Kohlgruber, Ph.D. (Boston Children's Hospital / Harvard Medical School)
Daniela Latorre, Ph.D. (San Raffaele University, Milan, Italy)
Louisa Müller-Miny, M.D. (University Hospital Münster, Germany)
Joseph Sabatino, M.D., Ph.D. (University of California, San Francisco)
Naresha Saligrama, Ph.D. (Washington University in St. Louis)
Michal Schwartz, Ph.D. (Weizmann Institute, Israel)
Alessandro Sette, Dr. Biol. Sci. (La Jolla Institute for Immunology)
Lawrence Stern, Ph.D. (UMass Chan Medical School)
Malu Tansey, Ph.D. (Indiana University)
Lisa Wagar, Ph.D. (University of California, Irvine)


The symposium will be held at Mayo Clinic's Integrated Education and Research Building (IERB) on the Phoenix campus. This state-of-the-art facility brings together scientists, physicians, educators, and trainees in a collaborative environment designed to advance biomedical research, education, and patient care.


THE VENUE


AGENDA

REGISTRaTION noW oPEN!

REGISTER TO ATTEND TCB 2027.

ABSTRACT SUBMISSION

SUBMIT YOUR ABSTRACT FOR TCB 2027.

STEERING 

COMMITTEE

wassim elyaman 

Mayo Clinic | Chair       

malú g. tansey

Indiana University | Co-Chair

sandro dá mesquita

Mayo Clinic

elizabeth m. bradshaw

Mayo Clinic

       OZGUN GOKCE       

University of Bonn

     ashley harms       

UAB